Novartis AG Profit Loss From Discontinued Operations
Novartis AG (NVSEF) reported Profit Loss From Discontinued Operations of $6.28 billion for the 12-month period ending 2023-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:ProfitLossFromDiscontinuedOperations · last filed 2026-02-04
- Novartis AG profit loss from discontinued operations for the quarter ending 2023-06-30 was $46.00M.
- Novartis AG profit loss from discontinued operations for the quarter ending 2019-06-30 was $4.69B, a 11627.50% increase year-over-year.
- Novartis AG profit loss from discontinued operations for the quarter ending 2018-06-30 was $40.00M.
| Period end | Profit Loss From Discontinued Operations 3 month | Profit Loss From Discontinued Operations 6 month | Profit Loss From Discontinued Operations 12 month |
|---|---|---|---|
| 2023-12-31 | $6.28B 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $46.00M 6-K · filed 2024-07-18 | $190.00M 6-K · filed 2024-07-18 | |
| 2022-12-31 | $906.00M 20-F · filed 2025-01-31 | ||
| 2021-12-31 | $1.11B 20-F · filed 2024-01-31 | ||
| 2019-12-31 | $4.59B 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $4.69B 6-K · filed 2020-07-21 | $4.59B 6-K · filed 2020-07-21 | |
| 2018-12-31 | -$186.00M 20-F · filed 2021-01-26 | ||
| 2018-06-30 | $40.00M 6-K · filed 2019-07-18 | $98.00M 6-K · filed 2019-07-18 | |
| 2017-12-31 | $204.00M 20-F · filed 2020-01-29 | ||
| 2015-12-31 | $10.77B 6-K · filed 2018-01-24 |